Author: Thevarajan, Irani; Buising, Kirsty L; Cowie, Benjamin C
Title: Clinical presentation and management of COVIDâ€19 Cord-id: 6fte7krp Document date: 2020_7_17
ID: 6fte7krp
Snippet: The rapid spread of severe acute respiratory syndrome coronavirus 2 led to the declaration of a global pandemic within 3 months of its emergence. The majority of patients presenting with coronavirus disease 2019 (COVIDâ€19) experience a mild illness that can usually be managed in the community. Patients require careful monitoring and early referral to hospital if any signs of clinical deterioration occur. Increased age and the presence of comorbidities are associated with more severe disease an
Document: The rapid spread of severe acute respiratory syndrome coronavirus 2 led to the declaration of a global pandemic within 3 months of its emergence. The majority of patients presenting with coronavirus disease 2019 (COVIDâ€19) experience a mild illness that can usually be managed in the community. Patients require careful monitoring and early referral to hospital if any signs of clinical deterioration occur. Increased age and the presence of comorbidities are associated with more severe disease and poorer outcomes. Treatment for COVIDâ€19 is currently predominantly supportive care, focused on appropriate management of respiratory dysfunction. Clinical evidence is emerging for some specific therapies (including antiviral and immuneâ€modulating agents). Investigational therapies for COVIDâ€19 should be used in the context of approved randomised controlled trials. Australian clinicians need to be able to recognise, diagnose, manage and appropriately refer patients affected by COVIDâ€19, with thousands of cases likely to present over the coming years.
Search related documents:
Co phrase search for related documents- abdominal pain and acute respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- abdominal pain and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- abdominal pain and admission duration: 1, 2
- abdominal pain and lopinavir ritonavir: 1, 2, 3, 4
- abdominal pain and low dose dexamethasone: 1
- abdominal pain and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9
- acute inflammatory syndrome and adjunctive treatment: 1, 2
- acute inflammatory syndrome and lopinavir ritonavir: 1, 2, 3
- acute inflammatory syndrome and lymphocyte count: 1, 2
- acute inpatient care and lymphocyte count: 1
- acute respiratory distress syndrome and adjunctive treatment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- acute respiratory distress syndrome and admission duration: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
- acute respiratory distress syndrome and load reduction: 1, 2
- acute respiratory distress syndrome and local institutional: 1
Co phrase search for related documents, hyperlinks ordered by date